Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Managing risks is key

Borja et. al. 20- postdoctoral research fellow at the Center for Global Security Research (CGSR) at Lawrence Livermore National Laboratory AND** Fellow at the Center for Global Security Research (CGSR) AND** research associate at the Center for Global Security Research (CGSR) at Lawrence Livermore National Laboratory AND** postdoctoral research fellow at the Center for Global Search Research AND** postdoctoral research fellow at the Center for Global Security Research (CGSR) (Lauren, Alexander Campbell, Marigny Kirschke-Schwartz, Brian Radzinsky, Brandon Williams, “Rethinking U.S. Biosecurity Strategy for the Decade Ahead (Workshop Summary),” Center for Global Security Research, 10-29-20, Accessed Online at https://www.osti.gov/servlets/purl/1735810, Accessed Online on 6-21-22)

The prevailing approach to managing pandemic risks is to quickly detect and respond to infectious diseases as they arise. The tools for doing so have steadily improved since the 1980s. Panelists cited two in particular: first, in the mid-1990s, U.S. and Israeli support developed the Global Infectious Disease and Epidemiology Network, a unified online software platform for diagnosing diseases and identifying potential treatments. With the twin advent of genomic science and improved computing power, U.S. universities and federally funded research centers developed significant bioinformatics capabilities to aid in the processing of emergent pandemic data and the identification of responses. The widespread use of relatively inexpensive, high throughput genomic sequencing has aided bioinformatics efforts and may aid in characterizing the risks of future pandemics. The genomes of over 2000 viruses have been sequenced thus far, although approximately 300,000 mammalian viruses remain unsequenced. In contrast, success in predicting the emergence of harmful pathogens has proved more elusive. A stronger worldwide surveillance system that monitors people with novel and unusual diseases would provide additional early warning before pandemics emerge. However, there are domestic and geopolitical barriers to the development of such a surveillance system. Governments are hesitant to provide external researchers with the kind of access necessary to conduct good disease surveillance, while sustained access might require a degree of international cooperation that is unrealistic in an era of renewed interstate competition. In addition, all pathogens are somewhat unique, and the emergence of a particularly virulent infectious diseases can overwhelm the ability of public and private sector actors to prevent spread of a contagion and rapidly produce vaccines and treatments. These challenges affect both man-made and natural pathogens. Man-made threats are further complicated by the dual-uses of many emerging biotechnologies which lack effective means for establishing norms to enforce their misuse. Early warning and response could also be significantly improved with a better understanding of which pathogens might infect humans and cause adverse effects. This could contribute to efforts to anticipate natural pathogens as well as potential man-made threats. A framework for understanding the movement of pathogens from animal to human hosts would involve several aspects, including identifying whether animals and humans share particular cell receptors that would allow for infection, the intracellular components that would allow viruses to replicate, and the mechanism of cross-species transmission. Panelists also identified the importance of studying single- and double-stranded RNA and DNA viruses to better understand their replication. The U.S. government through DARPA and other funding has sponsored several efforts to develop tools for anticipating future pandemics. Nevertheless, such efforts must contend with the unique attributes of otherwise related pathogens. For instance, SARS-CoV-2, the novel coronavirus that causes COVID-19, proved to be more infectious and more harmful than other coronaviruses. 5 Nevertheless, panelists emphasized that it was too costly an effort to study all identified viruses to understand potential risks. A more fruitful approach was to invest in better global biosurveillance to filter out “signals” from “noise”—that is, to leverage the capabilities of the global health community to provide credible early warning when potential pathogens first begin to spread. While there is national interest in anticipating emerging threats, participants did not identify a clear path forward for U.S. government efforts. One recommendation was that the U.S. Intelligence Community reassess its standards for confidence when making judgments about potential pandemic risks. Excessively high confidence requirements for community acceptance of judgments could, the argument goes, limit further study of a potential threat. Another recommendation was to leverage artificial intelligence and computing capabilities to better mine large data sources for insight into emergent threats.

Sign in to recut, update, or save this card.